tiprankstipranks
Trending News
More News >
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126

JW (Cayman) Therapeutics Co. Ltd. (2126) Revenue

Compare
0 Followers

JW (Cayman) Therapeutics Co. Ltd. Revenue

JW (Cayman) Therapeutics Co. Ltd. had a revenue of 71.40M in the quarter ending Dec 31, 2024, with -17.75%. This bring the company's revenue in the last twelve months to 158.22M, Increased -8.51%. In the fiscal year ending Dec 31, 2024, JW (Cayman) Therapeutics Co. Ltd. had annual revenue of 158.22M with -8.99% growth.
Revenue (ttm)
158.22M
Revenue Growth
-10.78%
P/S Ratio
4.55
Revenue/Employee
HK$563,053
Employees
281
Market Cap
HK$720.02M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
158.22M-15.64M-8.99%
Dec 31, 2023
173.86M28.15M+19.32%
Dec 31, 2022
145.70M114.91M+373.10%
Dec 31, 2021
30.80M+∞%
Dec 31, 2020
0.00-5.48M-100.00%
Dec 31, 2019
5.48M5.27M+2,450.23%
Dec 31, 2018
215.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis